Skip to main navigation

Shockwave Medical

Technology
- Challenges of Calcium
- Intravascular Lithotripsy (IVL)
Applications
Education
- Calcium IVLeague
- The Catalyst
Resources
- IFU Portal
- Reimbursement
Investors
About
- Our Story
- People
- Careers
- Patents
- Press Releases
- Contact

Technology
- Challenges of Calcium
- Intravascular Lithotripsy (IVL)
Applications
Education
- Calcium IVLeague
- The Catalyst
Resources
- IFU Portal
- Reimbursement
Investors
About
- Our Story
- People
- Careers
- Patents
- Press Releases
- Contact

Home / Investors / News & Events / Presentations

Investor Relations
Shareholder Tools

Presentations

Presentations

Investor Presentation November 2021

DISRUPT PAD III Investor Event Presentation

Intravascular Lithotripsy for Treatment of Severely Calcified Coronary Artery Disease: The Disrupt CAD III Study

Shockwave Medical

Corporate Headquarters
5403 Betsy Ross Drive
Santa Clara, CA 95054
United States

1-877-77-LITHO (775-4846)

Technology
- Challenges of Calcium
- Intravascular Lithotripsy
Applications
- US
- Peripheral
- Coronary
- TF Access
- International
- Peripheral
- Coronary
- TF Access
Education
- Ca++ IVLeague
- The Catalyst
Resources
- IFU Portal
- Reimbursement
Investors
About Us
- Our Story
- People
- Careers
- Patents
- Press Releases
- Contact

Follow Us

Prior to use, please reference the Instructions for Use for more information on indications, contraindications, warnings, precautions and adverse events.

Footer

Privacy Policy
Do Not Sell My Personal Information
Patents
Peripheral ISI
Coronary ISI (US)
Coronary ISI (Intl.)

© 2022 Shockwave Medical, Inc. All rights reserved. | SPL 62619 Rev. C